Fluidigm Corp
Change company Symbol lookup
Select an option...
FLDM Fluidigm Corp
AAPL Apple Inc
NXPI NXP Semiconductors NV
PRTK Paratek Pharmaceuticals Inc
VTR Ventas Inc
GBIM Globeimmune Inc
SCKT Socket Mobile Inc
BK Bank of New York Mellon Corp
BAC Bank of America Corp
AACG ATA Creativity Global
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Price
Delayed
$7.40
Day's Change
0.645 (9.56%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.68
Day's Low
7.00
Volume
(Heavy Day)

Today's volume of 3,315,546 shares is on pace to be much greater than FLDM's 10-day average volume of 2,206,887 shares.

3,315,546

FLDM's position in the Life Sciences Tools & Services industry

Industry PeersFLDMTECHNSTG

Summary

Company ProfileFluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics...
Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein...
Go to TECH summary
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The...
Go to NSTG summary
52-Week Change

VS. INDUSTRY
56.61%
31.50%
81.21%
Market Cap

VS. INDUSTRY
$481.4M
$10.2B
$1.7B
Beta

VS. INDUSTRY
1.9
1.1
1.5
Dividend Yield

VS. INDUSTRY
--
0.48%
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
45.71x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$112.6M
$738.7M
$116.7M
Profit Margin

VS. INDUSTRY
-48.46%
31.04%
-55.26%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
14.97%
--
Revenue Growth (TTM)

VS. INDUSTRY
-5.84%
3.46%
0.05%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.